Posts Tagged Theresa Zesiewicz

FARA-USF scientific symposium advances toward treatment for Friedreich’s ataxia

The Friedreich’s Ataxia Scientific Symposium: Understanding a Cure recently marked its 9th year of bringing dedicated scientists, clinicians, and industry partners with patients and their families to USF […]

Patients at center of 8th annual FARA-USF scientific symposium

Patients have always been the center of the yearly scientific symposium hosted by the Friedreich’s Ataxia Research Alliance (FARA) and the University of South Florida Ataxia Research Center. […]

USF Health and FARA to host patient-focused scientific symposium Sept. 15 [Video]

International experts from academia and industry will gather to discuss advances in Friedreich’s ataxia from the laboratory to the clinic. Tampa, FL (Sept. 12, 2016) — The University of […]

Symposium highlights new research by industry leaders seeking first treatment for Friedreich’s ataxia [video]

Hosted by FARA and the USF Ataxia Research Center, the annual scientific symposium emphasizes a patient-centered approach to research For the first time in its seven-year history, the […]

USF Health and FARA to host Sept. 17 scientific symposium

Pharma, biotech leaders will discuss several new clinical studies testing drugs and gene therapy for Friedreich’s ataxia Tampa, FL (Aug. 31, 2015) — The University of South Florida (USF) […]

Motorcycle ride to benefit USF Parkinson’s disease center

The fundraiser teams patient with USF neurologist who studies new treatments for the neurodegenerative disease Tampa, FL (Feb. 18, 2015) – The first time his right arm froze […]

USF studies potential new treatment for ED in patients with Parkinson’s disease

Tampa, FL (Dec. 2, 2014) — The University of South Florida (USF) Morsani College of Medicine is conducting a clinical research study on erectile dysfunction (ED) in patients […]

FDA fast tracks Friedreich’s ataxia drug undergoing testing in USF-led trial

The U.S. Food and Drug Administration yesterday designated fast-track status to EPI-743 for the treatment of Friedreich’s ataxia – a move that will help accelerate clinical development of […]

Edison, FARA and USF announce EPI-743 Phase 2 Friedreich’s ataxia clinical trial in adults with point mutations

First patient enrolled to evaluate investigational drug’s effectiveness  in rare Friedreich’s ataxia genotype Mountain View, CA; Downingtown, PA; & Tampa, FL (Nov. 4, 2013) — Edison Pharmaceuticals, the […]

Scientific symposium covers research behind the “therapeutic revolution” in Friedreich’s ataxia

A record crowd of more than 200 attended the fifth annual Scientific Symposium hosted Sept. 5 by USF and the Friedreich’s Ataxia Research Alliance  (FARA). There was standing […]